Apellis Pharmaceuticals I... (APLS)

NASDAQ: APLS · Real-Time Price · USD

20.37

0.29 (1.44%)

At close: May 02, 2025, 3:17 PM

Apellis Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	411.29M	351.19M	551.8M	640.19M	565.78M	351.99M	176.27M	175.64M	24.86M
Short-Term Investments	n/a	1.11M	6.5M	60.36M	311.87M	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	3.24M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	77.06M	-1.93M	15.8M	31.64M	18.86M	385.09K	116.42K	116.15K	64.53K
Receivables	271.72M	206.44M	7.73M	10.1M	25M	n/a	n/a	n/a	n/a
Inventory	81.4M	146.36M	85.71M	16.29M	1.00	n/a	n/a	n/a	n/a
Other Current Assets	6.17M	22.41M	36.66M	72.24M	11.14M	1.31M	1.84M	1.31M	1.37M
Total Current Assets	788.95M	766.33M	719.52M	824.05M	917.19M	373.09M	202.44M	182.02M	27.37M
Property-Plant & Equipment	19.04M	21.09M	24.89M	26.08M	24.52M	15.77M	977.92K	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	96.1M	22.4M	40.69M	57.72M	43.38M	16.15M	1.09M	116.15K	64.53K
Total Assets	885.05M	788.73M	760.22M	881.76M	960.57M	389.24M	203.53M	182.13M	27.43M
Account Payables	38.57M	37.52M	37.34M	16.91M	8.48M	8.36M	10.25M	3.66M	2.55M
Deferred Revenue	n/a	n/a	n/a	103.24M	111.94M	n/a	n/a	n/a	n/a
Short-Term Debt	6.75M	n/a	n/a	n/a	n/a	2.61M	1.67M	n/a	n/a
Other Current Liabilities	140.18M	75.83M	81.43M	7.58M	4.23M	40.73M	n/a	n/a	n/a
Total Current Liabilities	185.51M	247.59M	167.61M	131.85M	128.33M	65.75M	17.02M	6.55M	3.64M
Long-Term Debt	452.83M	93.03M	92.74M	189.02M	358.83M	142.57M	25.38M	26.39M	n/a
Other Long-Term Liabilities	7.97M	242.13M	315.65M	345.15M	253.64M	134.84M	158.78K	244.29K	n/a
Total Long-Term Liabilities	471M	346.62M	422.74M	551.26M	627.68M	289.26M	25.54M	26.63M	n/a
Total Liabilities	656.51M	594.21M	590.35M	683.1M	756.01M	355.02M	42.56M	33.19M	3.64M
Total Debt	469.78M	110.93M	112.71M	210.22M	377.73M	157.03M	27.04M	26.39M	n/a
Common Stock	12K	12K	11K	10K	8K	6.39K	5.63K	5.03K	843.00
Retained Earnings	-3.04B	-2.84B	-2.31B	-1.66B	-926.35M	-581.47M	-276.77M	-149.26M	-98.26M
Comprehensive Income	-3.31M	-3.54M	-875K	-2.09M	-117K	-153.78K	-122.81K	n/a	n/a
Shareholders Equity	228.54M	194.52M	169.87M	198.66M	204.56M	34.23M	160.97M	148.94M	23.79M
Total Investments	n/a	4.35M	6.5M	60.36M	311.87M	n/a	n/a	n/a	n/a